Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasis.

Dendy MS, Ludwig JM, Kim HS.

Oncotarget. 2017 Jun 6;8(23):37912-37922. doi: 10.18632/oncotarget.16007. Review.

2.

NDRG2 gene copy number is not altered in colorectal carcinoma.

Lorentzen A, Mitchelmore C.

World J Clin Oncol. 2017 Feb 10;8(1):67-74. doi: 10.5306/wjco.v8.i1.67.

3.

Advances in Biomarkers: Going Beyond the Carcinoembryonic Antigen.

Lopez NE, Peterson CY.

Clin Colon Rectal Surg. 2016 Sep;29(3):196-204. doi: 10.1055/s-0036-1584289. Review.

4.

Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances.

Lech G, Słotwiński R, Słodkowski M, Krasnodębski IW.

World J Gastroenterol. 2016 Feb 7;22(5):1745-55. doi: 10.3748/wjg.v22.i5.1745. Review.

5.

Determination of Effective Factors on Survival of GI Cancers: Results of Five Years Follow up in Iranian Population.

Zargar A, Miroliaee A, Ahmadi Gooraji S, Hajaghamohammadi A.

Glob J Health Sci. 2015 Nov 17;8(6):256-66. doi: 10.5539/gjhs.v8n6p256.

6.

Molecular backgrounds of ERAP1 downregulation in cervical carcinoma.

Mehta AM, Osse M, Kolkman-Uljee S, Fleuren GJ, Jordanova ES.

Anal Cell Pathol (Amst). 2015;2015:367837. doi: 10.1155/2015/367837. Epub 2015 Jun 4.

7.

Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer.

Wei XL, Wang DS, Xi SY, Wu WJ, Chen DL, Zeng ZL, Wang RY, Huang YX, Jin Y, Wang F, Qiu MZ, Luo HY, Zhang DS, Xu RH.

World J Gastroenterol. 2014 Dec 28;20(48):18404-12. doi: 10.3748/wjg.v20.i48.18404.

8.

Prognostic and predictive significance of MSI in stages II/III colon cancer.

Saridaki Z, Souglakos J, Georgoulias V.

World J Gastroenterol. 2014 Jun 14;20(22):6809-14. doi: 10.3748/wjg.v20.i22.6809. Review.

9.

Biomarkers in precision therapy in colorectal cancer.

Reimers MS, Zeestraten EC, Kuppen PJ, Liefers GJ, van de Velde CJ.

Gastroenterol Rep (Oxf). 2013 Nov;1(3):166-83. doi: 10.1093/gastro/got022. Epub 2013 Aug 23.

10.

Mechanisms of obesity-induced gastrointestinal neoplasia.

Alemán JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR.

Gastroenterology. 2014 Feb;146(2):357-373. doi: 10.1053/j.gastro.2013.11.051. Epub 2013 Dec 6. Review.

11.

Review of histopathological and molecular prognostic features in colorectal cancer.

Marzouk O, Schofield J.

Cancers (Basel). 2011 Jun 23;3(2):2767-810. doi: 10.3390/cancers3022767.

12.

Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention.

Colussi D, Brandi G, Bazzoli F, Ricciardiello L.

Int J Mol Sci. 2013 Aug 7;14(8):16365-85. doi: 10.3390/ijms140816365. Review.

13.

Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.

Hansen AG, Freeman TJ, Arnold SA, Starchenko A, Jones-Paris CR, Gilger MA, Washington MK, Fan KH, Shyr Y, Beauchamp RD, Zijlstra A.

Cancer Res. 2013 May 15;73(10):2955-64. doi: 10.1158/0008-5472.CAN-12-2052. Epub 2013 Mar 28.

14.

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.

Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E.

Mod Pathol. 2013 Apr;26(4):465-84. doi: 10.1038/modpathol.2012.214. Epub 2013 Jan 11. Review.

15.

Serrated colon polyps as precursors to colorectal cancer.

Sweetser S, Smyrk TC, Sinicrope FA.

Clin Gastroenterol Hepatol. 2013 Jul;11(7):760-7; quiz e54-5. doi: 10.1016/j.cgh.2012.12.004. Epub 2012 Dec 23.

16.

Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers.

Bond CE, Umapathy A, Buttenshaw RL, Wockner L, Leggett BA, Whitehall VL.

PLoS One. 2012;7(10):e47483. doi: 10.1371/journal.pone.0047483. Epub 2012 Oct 22.

17.

Transcriptome profiling of the cancer, adjacent non-tumor and distant normal tissues from a colorectal cancer patient by deep sequencing.

Wu Y, Wang X, Wu F, Huang R, Xue F, Liang G, Tao M, Cai P, Huang Y.

PLoS One. 2012;7(8):e41001. doi: 10.1371/journal.pone.0041001. Epub 2012 Aug 8.

18.

Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers.

Imamura Y, Morikawa T, Liao X, Lochhead P, Kuchiba A, Yamauchi M, Qian ZR, Nishihara R, Meyerhardt JA, Haigis KM, Fuchs CS, Ogino S.

Clin Cancer Res. 2012 Sep 1;18(17):4753-63. doi: 10.1158/1078-0432.CCR-11-3210. Epub 2012 Jul 2.

19.

Genetic alterations in colorectal cancer.

Armaghany T, Wilson JD, Chu Q, Mills G.

Gastrointest Cancer Res. 2012 Jan;5(1):19-27.

20.

TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers.

Shima K, Morikawa T, Yamauchi M, Kuchiba A, Imamura Y, Liao X, Meyerhardt JA, Fuchs CS, Ogino S.

PLoS One. 2011;6(9):e25062. doi: 10.1371/journal.pone.0025062. Epub 2011 Sep 20.

Supplemental Content

Support Center